Vrinda Nandi

Error message

Notice: Undefined index: localized_options in menu_navigation_links() (line 1861 of /home/bizmesol/public_html/prod/drupal-7/includes/menu.inc).

Primary tabs

1. Personal Information

Name
Vrinda Nandi
Organization(s)
Independent consultant, Formerly worked at AstraZeneca

2. Community Expertise

Malaria research
Tuberculosis research community
The Synaptic Leap community
Skills
Chemistry

3. Publications

Publications

1. Nayak, Vrinda; Kellogg, Glen Eugene. Cyclodextrin-barbiturate inclusion complexes: a CoMFA/HINT 3-D QSAR study. Medicinal Chemistry Research (1994), 3(8), 491-502.

2. Soine, William H.; Yu, Cheng-Fang; Thomas, Diana; Nayak, Vrinda; Cao, Si Lan; Westkaemper, Richard B. N-Glucosylation of 5,5-disubstituted barbiturates by mouse liver microsomes. Medicinal Chemistry Research (1995), 5(6), 462-77.

3. Nandi, Vrinda; Soine, William H. HPLC analysis for amobarbital N-glycosides in urine. Journal of Pharmaceutical and Biomedical Analysis (1997), 15(8), 87-1195.

4. Nandi, Vrinda. HTS: Rapid Assessment of Drug Properties, Express Pharma Pulse – Pharma Research Special edition, September 2001, Special edition, 44-49.

5. Nandi, Vrinda. Adverse Drug Reactions: Are Drugs Really Safe? Express Pharma Pulse – Pharma Research Special edition, August 2002, 35-39.

6. Jayaram, Ramesh; Gaonkar, Sheshagiri; Kaur, Parvinder; Suresh, B. L.; Mahesh, B. N.; Jayashree, R.; Nandi, Vrinda; Bharath, Sowmya; Shandil, R. K.; Kantharaj, E.; Balasubramanian, V. Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis. Antimicrobial Agents and Chemotherapy (2003), 47(7), 2118-2124.

7. Jayaram, Ramesh; Shandil, Radha. K.; Gaonkar, Sheshagiri; Kaur, Parvinder; Suresh, B. L.; Mahesh, B. N.; Jayashree, R.; Nandi, Vrinda; Bharath, Sowmya; Kantharaj, E.; Balasubramanian, V. Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis. Antimicrobial Agents and Chemotherapy (2004), 48(8), 2951-2957.

8. Fridén Markus; Vanaja K; Nandi Vrinda N.; Drug-drug interactions of anti-infective drugs: Utility of fluorescence CYP inhibition assays in drug discovery, Drug metabolism and drug interactions 2006, vol. 21, 3-4, p. 163-185

9. Radha K. Shandil, Ramesh Jayaram, Parvinder Kaur, Sheshagiri Gaonkar, B. L. Suresh, B. N. Mahesh, R. Jayashree, Vrinda Nandi, Sowmya Bharath, and V. Balasubramanian Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: Evaluation of In Vitro and Pharmacodynamic Indices That Best Predict In Vivo Efficacy. Antimicrobial Agents and Chemotherapy, February 2007, p. 576-582, Vol. 51, No. 2.

10. Vadim Makarov, Giulia Manina, Katarina Mikusova, Ute Mallman, Olga Ryabova, Brigitte Saint-Joanis, Neeraj Dhar, Maria Rosalia Pasca, Silvia Buroni, Anna Paola Lucarelli, Anna Milano, Edda De Rossi, Martina Belanova, Adela Bobovska, Petronela Dianiskova, Jana Kordulakova, Claudia Sala, Elizabeth Fullam, Patricia Schneider, John D McKinney, Priscille Brodin, Thierry Christophe, Simon Waddell, Philip Butcher, Jakob Albrethsen, Ida Rosenkrands, Roland Brosch, Vrinda Nandi, Sowmya Bharath, Sheshagiri Gaonkar, Radha K Shandil, Venkataraman Balasubramanian, Tanjore Balganesh, Sandeep Tyagi, Jacques Grosset, Giovanna Riccardi and Stewart T Cole. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 324 (5928):801-4 (2009)

History

Blog
View recent blog entries
Member for
7 years 8 months